Target
Receptor-type tyrosine-protein kinase FLT3 [572-603]
Ligand
BDBM621080
Substrate
n/a
Meas. Tech.
Kinase Binding Assay
Kd
9.80±n/a nM
Citation
 HOYT, SBTHOMAS, CJFINOCCHIO, CJSTARCZYNOWSKI, DTTAWA, GJGRACIA MALDONADO, GROSEBAUM, JS MULTI-CYCLIC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF US Patent  US20230303563 Publication Date 9/28/2023 
Target
Name:
Receptor-type tyrosine-protein kinase FLT3 [572-603]
Synonyms:
juxtamembrane domain of FLT3 (FLT3-JM-PMs) | The autoinhibitory JM domain of FLT3
Type:
Enzyme Catalytic Domain
Mol. Mass.:
4028.26
Organism:
Human
Description:
P36888[572-603]
Residue:
32
Sequence:
YESQLQMVQVTGSSDNEYFYVDFREYEYDLKW
  
Inhibitor
Name:
BDBM621080
Synonyms:
N-(6-(6-(1-methyl- cyclopropyl)imidazo- [1,2-a]pyridin-3-yl)- pyridin-2-yl)-2- azaspiro[3.4]octan-6- amine | US20230303563, Compound 13
Type:
Small organic molecule
Emp. Form.:
n/a
Mol. Mass.:
n/a
SMILES:
CC1(CC1)c1ccc2ncc(-c3cccc(NC4CCC5(CNC5)C4)n3)n2c1
Structure:
Search PDB for entries with ligand similarity: